Published by Josh White on 14th May 2020
(Sharecast News) - Specialist regional asset manager Mercia Asset Management announced on Thursday that transdermal drug delivery company Medherant, in which it holds a 30.1% direct stake, has entered into a partnership with Cycle Pharmaceuticals to develop new products using Medherant's proprietary 'TEPI Patch' technology.